Anette Karle

1.2k total citations
19 papers, 866 citations indexed

About

Anette Karle is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Anette Karle has authored 19 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Anette Karle's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (6 papers) and Protein purification and stability (4 papers). Anette Karle is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (6 papers) and Protein purification and stability (4 papers). Anette Karle collaborates with scholars based in Switzerland, United States and France. Anette Karle's co-authors include Sebastian Spindeldreher, Frank Kolbinger, Dafne Müller, Roland E. Kontermann, Ines Höfig, Roland Stork, Anne B. Vogt, Bernard Maillère, Gottfried Fischer and Barbara Bohle and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Allergy and Clinical Immunology.

In The Last Decade

Anette Karle

17 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anette Karle Switzerland	13	418	417	389	109	89	19	866
Wojciech Dawicki Canada	22	1.1k 2.7×	105 0.3×	271 0.7×	260 2.4×	21 0.2×	36	1.6k
Tripti Tamhane Germany	8	132 0.3×	25 0.1×	183 0.5×	88 0.8×	67 0.8×	13	436
Tyler Allison United States	10	174 0.4×	756 1.8×	697 1.8×	76 0.7×	8 0.1×	18	1.3k
Kelly Byrnes-Blake United States	15	195 0.5×	150 0.4×	272 0.7×	116 1.1×	16 0.2×	23	884
T Maeda Japan	15	248 0.6×	56 0.1×	131 0.3×	44 0.4×	89 1.0×	24	735
Nobuhiko Tada Japan	18	640 1.5×	419 1.0×	456 1.2×	82 0.8×	6 0.1×	53	1.0k
Fabien Pitoiset France	10	256 0.6×	23 0.1×	104 0.3×	72 0.7×	36 0.4×	12	464
Stephan Kissler Germany	20	586 1.4×	31 0.1×	360 0.9×	110 1.0×	3 0.0×	54	1.4k
Brigitte Miloux France	11	783 1.9×	113 0.3×	400 1.0×	214 2.0×	3 0.0×	13	1.4k
A. Marcadet France	11	300 0.7×	87 0.2×	90 0.2×	25 0.2×	23 0.3×	15	495

Countries citing papers authored by Anette Karle

Since Specialization

Citations

This map shows the geographic impact of Anette Karle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anette Karle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anette Karle more than expected).

Fields of papers citing papers by Anette Karle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anette Karle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anette Karle. The network helps show where Anette Karle may publish in the future.

Co-authorship network of co-authors of Anette Karle

This figure shows the co-authorship network connecting the top 25 collaborators of Anette Karle. A scholar is included among the top collaborators of Anette Karle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anette Karle. Anette Karle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Villiger, Thomas K., et al.. (2025). Host cell protein-mediated adjuvanticity and immunogenicity risks of biotherapeutics. Biotechnology Advances. 81. 108575–108575.

Karle, Anette, et al.. (2025). Assessing the Adjuvant Potential of Chinese Hamster Ovary Host Cell Proteins Using an In Vitro Dendritic Cell Assay. Biotechnology and Bioengineering. 122(5). 1105–1117. 2 indexed citations

Karle, Anette, Karla Kopp, Robert Seward, et al.. (2025). MAPPs assays for non-clinical immunogenicity risk assessment: best practices recommended by the European immunogenicity platform. Frontiers in Immunology. 16. 1690101–1690101.

Hanke, Alexander T., et al.. (2024). Host cell protein networks as a novel co‐elution mechanism during protein A chromatography. Biotechnology and Bioengineering. 121(5). 1716–1728. 8 indexed citations

Karle, Anette. (2020). Applying MAPPs Assays to Assess Drug Immunogenicity. Frontiers in Immunology. 11. 698–698. 35 indexed citations

Spindeldreher, Sebastian, et al.. (2020). T cell epitope mapping of secukinumab and ixekizumab in healthy donors. mAbs. 12(1). 1707418–1707418. 31 indexed citations

Spindeldreher, Sebastian, et al.. (2018). Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab. Dermatology and Therapy. 8(1). 57–68. 33 indexed citations

Spindeldreher, Sebastian, et al.. (2017). Massive immune response against IVIg interferes with response against other antigens in mice: A new mode of action?. PLoS ONE. 12(10). e0186046–e0186046. 7 indexed citations

Hamze, Moustafa, Anette Karle, Abdelaziz Gdoura, et al.. (2017). Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors. Frontiers in Immunology. 8. 500–500. 66 indexed citations

10.

Spindeldreher, Sebastian, et al.. (2017). Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg?. Immunity Inflammation and Disease. 5(4). 400–415. 13 indexed citations

11.

Webster, Carl I., Christine Bryson, Tim D. Jones, et al.. (2016). A comparison of the ability of the human IgG1 allotypes G1m3 and G1m1,17 to stimulate T-cell responses from allotype matched and mismatched donors. mAbs. 8(2). 253–263. 14 indexed citations

12.

Karle, Anette, Sebastian Spindeldreher, & Frank Kolbinger. (2016). Secukinumab, a novel anti–IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity. mAbs. 8(3). 536–550. 68 indexed citations

13.

Volkmuth, Wayne, José S. Duca, Michele Pallaoro, et al.. (2015). Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. WOS. 1 indexed citations

14.

Volkmuth, Wayne, José S. Duca, Michele Pallaoro, et al.. (2015). Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Science Translational Medicine. 7(294). 294ra105–294ra105. 162 indexed citations

15.

Karle, Anette, Babette Wolf, Marie‐Claude Djidja, et al.. (2014). Aggregation of Human Recombinant Monoclonal Antibodies Influences the Capacity of Dendritic Cells to Stimulate Adaptive T-Cell Responses In Vitro. PLoS ONE. 9(1). e86322–e86322. 116 indexed citations

16.

Karle, Anette, Gertie Janneke Oostingh, Sonja Mutschlechner, et al.. (2012). Nitration of the Pollen Allergen Bet v 1.0101 Enhances the Presentation of Bet v 1-Derived Peptides by HLA-DR on Human Dendritic Cells. PLoS ONE. 7(2). e31483–e31483. 57 indexed citations

17.

Mutschlechner, Sonja, Matthias Egger, Peter Briza, et al.. (2010). Naturally processed T cell–activating peptides of the major birch pollen allergen. Journal of Allergy and Clinical Immunology. 125(3). 711–718.e2. 47 indexed citations

18.

Mueller, Robert, Anette Karle, Anne B. Vogt, et al.. (2009). Evaluation of the Immuno-Stimulatory Potential of Stopper Extractables and Leachables by Using Dendritic Cells as Readout. Journal of Pharmaceutical Sciences. 98(10). 3548–3561. 36 indexed citations

19.

Müller, Dafne, et al.. (2007). Improved Pharmacokinetics of Recombinant Bispecific Antibody Molecules by Fusion to Human Serum Albumin. Journal of Biological Chemistry. 282(17). 12650–12660. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact